F
BSE
23,569.74
Last Updated on 20 Aug 2025 at 17:00
Open at
23,497.53
52W High
24,132.28
52W Low
22,583.39
Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.
High
23,619.07
Low
23,422.55
Open at
23,497.53
Prev Close
23,463.74
Volumes
0
Avg Price
0.00
Lower Circuit
0.00
Upper Circuit
0.00
Quantity
0
Time
17:00:01
3 M High
24,132.28
3 M Low
22,583.39
1 Yr High
24,132.28
1 Yr Low
22,583.39
3 Yr High
24,132.28
3 Yr Low
22,583.39
5 Yr High
24,132.28
5 Yr Low
22,583.39
Positive Stocks
10
Negative Stocks
10
Neutral Stocks
0
Dixon Technologies Block Trade Worth Rs 28.61 Crores Executed on NSE
A block trade involving Dixon Technologies was executed on the National Stock Exchange for approximately 16,811 shares at a price of Rs 17,021 per share. The total transaction value amounted to Rs 28.61 crores.
Aurobindo Pharma Denies $5.5 Billion Zentiva Acquisition Reports
Aurobindo Pharma has denied reports regarding a $5.5 billion acquisition of Zentiva, stating that no binding agreement has been reached between the companies.
Lupin Launches Bosentan Tablets in US Market with 180-Day Exclusivity
Lupin Limited launched Bosentan Tablets for Oral Suspension, 32 mg in the United States market. The launch follows approval received by Lupin's alliance partner NATCO Pharma Limited from the U.S. FDA for its Abbreviated New Drug Application. NATCO holds exclusive first-to-file status and will have 180-day generic drug exclusivity. The tablets are bioequivalent to Tracleer Tablets for Oral Suspension and are indicated for treating pulmonary arterial hypertension in pediatric patients aged 3 years and older. Bosentan Tablets had estimated annual sales of USD 10 million in the U.S. according to IQVIA data.
SRF Partners With Chemours For Fluoropolymer Manufacturing, Revenue Growth Expected From FY27
SRF Ltd. has entered a strategic partnership with Chemours Co. to manufacture fluoropolymers and fluoroelastomers at its Dahej facility. Production is expected to begin within 12 months, with revenue growth anticipated from fiscal 2027. The products serve semiconductor, automotive, aerospace, and oil and gas industries. SRF will leverage its manufacturing capabilities while Chemours provides technology, with no upfront capital investment required from Chemours. The partnership will utilize SRF's existing 5 kilotonnes per annum PTFE facility, which currently operates at 50-60% capacity. PTFE accounts for 3-4% of SRF's chemicals segment revenues. Analyst ratings vary: Citi maintains 'sell' with Rs 2,725 target, UBS maintains 'sell' with Rs 2,400 target, while DAM Capital maintains 'buy' with Rs 3,521 target. SRF shares closed 0.35% higher at Rs 2,929.6, having gained 31% over the past 12 months.
Aurobindo Pharma Emerges as Frontrunner for $5.5 Billion Zentiva Acquisition
Aurobindo Pharma has become the leading candidate to acquire Prague-based generic drugmaker Zentiva for $5-5.5 billion from Advent International. The deal would mark the largest acquisition by an Indian pharmaceutical company, surpassing previous records. Aurobindo is competing with US private equity firm GTCR in advanced negotiations. The company has secured a $4.75 billion credit line from MUFG as bridge financing, with the remaining $800 million from internal funds. Zentiva generated 1.7 billion euros in revenue for 2024 with 400 million euros EBITDA and operates in 30 countries. The acquisition would significantly expand Aurobindo's European presence, particularly in Eastern Europe markets including Czech Republic, Romania, and Slovakia. Aurobindo's market value stands at Rs 63,684.90 crore, while its European business grew 16.6% to Rs 8,356 crore. A formal announcement is expected within the next fortnight to month.
View More
Period | Simple | Signal |
---|---|---|
5-SMA | 23,216.74 | Bullish |
10-SMA | 23,017.57 | Bullish |
20-SMA | 23,142.53 | Bullish |
50-SMA | 0.00 | Bullish |
100-SMA | 0.00 | Bullish |
200-SMA | 0.00 | Bullish |
Indicator | Value | Action |
---|---|---|
RSI(14) | 56.26 | Neutral |
ATR(14) | 292.54 | Less Volatile |
STOCH(9,6) | 70.89 | Neutral |
STOCH RSI(14) | 100.00 | Overbought |
MACD(12,26) | 77.57 | Bullish |
ADX(14) | 30.78 | Strong Trend |
Summary of Technical Indicators for FOCMID
FOCMID Gainers | LTP | Change% | Weightage | Market Cap (Cr.) | PE Ratio | 52W High | 52W Low |
---|---|---|---|---|---|---|---|
C Colgate Palmolive | 2,356.70 | 3.64% | 3.843% | ₹ 61,835.90 | 44.39 | 3,893.00 | 2,151.00 |
C Coforge | 1,708.60 | 3.39% | 3.435% | ₹ 55,270.60 | 57.56 | 2,003.59 | 1,190.84 |
I Indus Towers | 349.05 | 2.69% | 5.574% | ₹ 89,684.30 | 9.40 | 460.70 | 312.65 |
P Persistent Systems | 5,345.70 | 2.10% | 5.090% | ₹ 81,898.90 | 53.92 | 6,788.80 | 4,163.80 |
C Cummins | 3,818.90 | 1.90% | 6.464% | ₹ 1,04,005.40 | 48.73 | 3,926.60 | 2,594.75 |
N Info Edge | 1,393.60 | 1.00% | 5.560% | ₹ 89,464.90 | 88.22 | 1,838.99 | 1,151.45 |
T Tube Investment | 3,182.90 | 1.00% | 3.791% | ₹ 60,997.00 | 93.87 | 4,807.05 | 2,400.05 |
P PB FinTech | 1,921.20 | 0.43% | 5.463% | ₹ 87,897.30 | 232.73 | 2,254.95 | 1,312.10 |
H Hero Motocorp | 5,135.65 | 0.34% | 6.362% | ₹ 1,02,372.00 | 20.32 | 6,245.00 | 3,322.60 |
Y Yes Bank | 19.36 | 0.05% | 3.772% | ₹ 60,686.80 | 22.24 | 24.84 | 16.02 |
Sectors | Companies | Weightage | Market Cap (Cr.) |
---|---|---|---|
Banks | 4 | 13.88% | 2,23,331.20 |
Consumer Goods | 2 | 10.20% | 1,64,073.40 |
Automobiles | 2 | 10.15% | 1,63,369.00 |
Healthcare | 2 | 9.52% | 1,53,195.10 |
Information Technology | 2 | 8.52% | 1,37,169.50 |
Capital Markets | 1 | 7.60% | 1,22,334.90 |
Industrial Products | 1 | 6.46% | 1,04,005.40 |
Capital Goods | 1 | 6.43% | 1,03,488.10 |
Telecom | 1 | 5.57% | 89,684.30 |
Retail | 1 | 5.56% | 89,464.90 |
Financial Services | 1 | 5.46% | 87,897.30 |
Chemicals | 1 | 5.40% | 86,840.60 |
Petroleum Products | 1 | 5.23% | 84,176.70 |
Close Price
Volume
FOCMID share price in last 10 trading sessions
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0.00% | -3.72% | 1.44% | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.00% |
1 Week
1 Month
3 Month
6 Month
9 Month
1 Year
2 Years
3 Years
4 Years
5 Years
1 Week
1 Month
3 Month
6 Month
9 Month
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Name | LTP | Change | Change % | 1M Returns | 3M Returns | 6M Returns | 1Y Returns | 3Y Returns | 5Y Returns |
---|---|---|---|---|---|---|---|---|---|
B BSE Focused Midcap | ₹ 23,569.74 | 106.00 | 0.45% | -1.78% | 0.99% | 0.99% | 0.99% | 0.99% | 0.99% |
N Nifty Midcap Select | ₹ 12,999.80 | 91.50 | 0.71% | -2.26% | 3.31% | 14.12% | 1.02% | 79.51% | 68.02% |
S Sensex Next 50 Index | ₹ 84,276.77 | 394.96 | 0.47% | -0.58% | 3.15% | 12.55% | -0.88% | 71.42% | 71.64% |
N NIFTY Midcap 150 | ₹ 21,566.10 | 99.25 | 0.46% | -1.96% | 4.36% | 14.17% | 0.17% | 87.70% | 237.00% |
N Nifty Next 50 | ₹ 68,164.30 | 256.85 | 0.38% | -0.49% | 3.02% | 11.67% | -7.85% | 61.00% | 146.19% |
N NIFTY Smallcap 250 | ₹ 17,064.50 | 58.05 | 0.34% | -4.62% | 4.25% | 15.56% | -3.77% | 90.45% | 67.00% |
N NIFTY 500 | ₹ 23,143.15 | 76.55 | 0.33% | -1.01% | 2.47% | 11.10% | -0.59% | 54.27% | 147.02% |
B BSE 100 | ₹ 26,266.23 | 82.51 | 0.32% | -0.31% | 1.74% | 9.71% | 0.29% | 46.85% | 129.25% |
B BSE 500 | ₹ 36,323.56 | 112.23 | 0.31% | -0.99% | 2.28% | 10.89% | -1.20% | 51.82% | 144.13% |
N NIFTY 100 | ₹ 25,689.30 | 76.00 | 0.30% | -0.22% | 1.75% | 9.73% | -0.36% | 44.38% | 123.79% |
N Nifty 50 | ₹ 25,050.55 | 69.90 | 0.28% | -0.16% | 1.49% | 9.33% | 1.42% | 43.22% | 121.45% |
S Sensex | ₹ 81,857.84 | 213.45 | 0.26% | -0.42% | 0.83% | 8.08% | 1.31% | 39.28% | 114.17% |
Name | LTP | Change% | High | Low |
---|---|---|---|---|
B BSE Focused Midcap | ₹ 23,569.74 | 0.45% | ₹ 23,619.07 | ₹ 23,422.55 |
C Colgate Palmolive | ₹ 2,356.70 | 3.64% | ₹ 2,364.95 | ₹ 2,264.20 |
C Coforge | ₹ 1,708.60 | 3.39% | ₹ 1,721.20 | ₹ 1,632.85 |
I Indus Towers | ₹ 349.05 | 2.69% | ₹ 355.00 | ₹ 341.50 |
P Persistent Systems | ₹ 5,345.70 | 2.10% | ₹ 5,369.35 | ₹ 5,207.80 |
C Cummins | ₹ 3,818.90 | 1.90% | ₹ 3,833.90 | ₹ 3,735.20 |
I Info Edge | ₹ 1,393.60 | 1.00% | ₹ 1,398.85 | ₹ 1,364.50 |
T Tube Investment | ₹ 3,182.90 | 1.00% | ₹ 3,252.50 | ₹ 3,138.65 |
Date | Stock Name | Event | LTP (1D Change%) | Details |
---|---|---|---|---|
22nd Aug 2025, Friday | ||||
F Federal Bank | Dividend | ₹ 203.42 (-0.30%) | Final Dividend of ₹1.2 Per Share |
F
Federal Bank
Event
LTP (1D Chg%)
₹ 203.42 (-0.30%)
Details
The above dates are ex-dates.
View All Stock EventsPay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App
Explore | Sitemap
*All securities mentioned on this website are exemplary and not recommendatory.
*Current prices on the website are delayed by 15 mins, login to check live prices.
We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.
Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.
That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.
©2021-2025 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.
In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.
Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.
DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances
Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit
Attention investors:
Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.
Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.
Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/
Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX
Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets